SIG — Sigma Healthcare Balance Sheet
0.000.00%
- AU$33.12bn
- AU$35.05bn
- AU$4.93bn
- 71
- 15
- 70
- 53
Annual balance sheet for Sigma Healthcare, fiscal year end - January 31st, AUD millions except per share, conversion factor applied.
R2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | 2025 January 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Interim Report | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 16.1 | 31.2 | 16.6 | 356 | 14.6 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 327 | 359 | 337 | 320 | 961 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 702 | 762 | 686 | 913 | 1,377 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 288 | 282 | 291 | 272 | 256 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,185 | 1,248 | 1,174 | 1,378 | 1,831 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 524 | 458 | 477 | 371 | 865 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 671 | 761 | 698 | 507 | 993 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 514 | 487 | 476 | 871 | 838 |
| Total Liabilities & Shareholders' Equity | 1,185 | 1,248 | 1,174 | 1,378 | 1,831 |
| Total Common Shares Outstanding |